Nanjing Vishee Medical Technology Co., Ltd
Символ: 688580.SS
SHH
43.3
CNYПазарна цена днес
21.6547
Съотношение P/E
0.0000
Коефициент PEG
2.95B
MRK Cap
- 0.02%
Доходност на DIV
Nanjing Vishee Medical Technology Co., Ltd (688580-SS) финансови отчети
Баланс
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2014 | 2013 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 4653.82 | 1133.2 | 1248.1 | 1366 | ||||||||||
balance-sheet.row.short-term-investments | 2262.96 | 2266.4 | 0 | 0 | ||||||||||
balance-sheet.row.net-receivables | 109.53 | 0 | 31.9 | 36.7 | ||||||||||
balance-sheet.row.inventory | 122.49 | 0 | 34.8 | 30.4 | ||||||||||
balance-sheet.row.other-current-assets | 24.86 | 0 | 4.3 | 1.2 | ||||||||||
balance-sheet.row.total-current-assets | 4910.69 | 1133.2 | 1319.2 | 1434.3 | ||||||||||
balance-sheet.row.property-plant-equipment-net | 767.48 | 0 | 172.5 | 100.3 | ||||||||||
balance-sheet.row.goodwill | 207.92 | 0 | 69.3 | 0 | ||||||||||
balance-sheet.row.intangible-assets | 332.36 | 0 | 106.5 | 18.8 | ||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 540.28 | 0 | 175.8 | 18.8 | ||||||||||
balance-sheet.row.long-term-investments | 49.4 | 0 | 0 | 0.8 | ||||||||||
balance-sheet.row.tax-assets | 29.06 | 0 | 7.9 | 12.7 | ||||||||||
balance-sheet.row.other-non-current-assets | -1121.64 | -1133.2 | 8.8 | 71.9 | ||||||||||
balance-sheet.row.total-non-current-assets | 264.58 | -1133.2 | 365 | 204.4 | ||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | ||||||||||
balance-sheet.row.total-assets | 5175.27 | 0 | 1684.2 | 1638.7 | ||||||||||
balance-sheet.row.account-payables | 60.85 | 0 | 19.7 | 9.3 | ||||||||||
balance-sheet.row.short-term-debt | -3.81 | 0 | 1.2 | 1.2 | ||||||||||
balance-sheet.row.tax-payables | 53.75 | 0 | 21.1 | 29.3 | ||||||||||
balance-sheet.row.long-term-debt-total | 0 | 0 | 0 | 1.8 | ||||||||||
Deferred Revenue Non Current | 0.4 | 0 | 0 | 0 | ||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 1.55 | - | - | - | ||||||||||
balance-sheet.row.other-current-liab | 213.59 | 0 | 94.8 | 1.6 | ||||||||||
balance-sheet.row.total-non-current-liabilities | 81.4 | 0 | 26.4 | 1.8 | ||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | ||||||||||
balance-sheet.row.capital-lease-obligations | 27.42 | 0 | 1.2 | 1.8 | ||||||||||
balance-sheet.row.total-liab | 482.44 | 0 | 155.7 | 105.7 | ||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | ||||||||||
balance-sheet.row.common-stock | 205.87 | 0 | 68.6 | 68.3 | ||||||||||
balance-sheet.row.retained-earnings | 1155.73 | 0 | 349.1 | 344.3 | ||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 3889.34 | 1588.9 | 34.8 | 58.1 | ||||||||||
balance-sheet.row.other-total-stockholders-equity | 1030.79 | 0 | 1076 | 1062.3 | ||||||||||
balance-sheet.row.total-stockholders-equity | 6281.74 | 1588.9 | 1528.5 | 1533.1 | ||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 6764.18 | 1588.9 | 1684.2 | 1638.7 | ||||||||||
balance-sheet.row.minority-interest | 0 | 0 | 0 | 0 | ||||||||||
balance-sheet.row.total-equity | 6281.74 | 1588.9 | 1528.5 | 1533.1 | ||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 6764.18 | - | - | - | ||||||||||
Total Investments | 2312.36 | 2266.4 | 0 | 0.8 | ||||||||||
balance-sheet.row.total-debt | 2.46 | 0 | 1.2 | 3 | ||||||||||
balance-sheet.row.net-debt | -2385.01 | 1133.2 | -1246.9 | -1363 |
Отчет за паричните потоци
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2014 | 2013 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 136.43 | 93.8 | 177.5 | 143.1 | |||||||||
cash-flows.row.depreciation-and-amortization | 1.21 | 17.1 | 11.1 | 8.8 | |||||||||
cash-flows.row.deferred-income-tax | -1.21 | 2.3 | -8.1 | -1.1 | |||||||||
cash-flows.row.stock-based-compensation | 3.02 | -2.8 | 21.4 | 1.1 | |||||||||
cash-flows.row.change-in-working-capital | 0 | -8.7 | -33.5 | -19.1 | |||||||||
cash-flows.row.account-receivables | 0 | 7.3 | -13.1 | -15.9 | |||||||||
cash-flows.row.inventory | 0 | 1.8 | 6.7 | -5.6 | |||||||||
cash-flows.row.account-payables | 0 | -20.1 | -19 | 3.4 | |||||||||
cash-flows.row.other-working-capital | 0 | 2.3 | -8.1 | -1.1 | |||||||||
cash-flows.row.other-non-cash-items | -42.05 | -15.6 | -11 | -12.1 | |||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 94.38 | 0 | 0 | 0 | |||||||||
cash-flows.row.investments-in-property-plant-an-equipment | -103.09 | -95.6 | -87.3 | -11.7 | |||||||||
cash-flows.row.acquisitions-net | -20.1 | -34.2 | 0 | 11.7 | |||||||||
cash-flows.row.purchases-of-investments | -1822 | -3648 | -4264 | -2102.4 | |||||||||
cash-flows.row.sales-maturities-of-investments | 1806.14 | 3664 | 4284.6 | 2115.8 | |||||||||
cash-flows.row.other-investing-activites | 1.9 | 9 | -10 | -11.7 | |||||||||
cash-flows.row.net-cash-used-for-investing-activites | -137.15 | -104.8 | -76.8 | 1.9 | |||||||||
cash-flows.row.debt-repayment | 0 | -2 | -1.3 | -14 | |||||||||
cash-flows.row.common-stock-issued | 0 | 16.9 | -0.3 | -18 | |||||||||
cash-flows.row.common-stock-repurchased | 0 | -14.9 | 1.6 | 18 | |||||||||
cash-flows.row.dividends-paid | -2.64 | -88.9 | -71.8 | -50.3 | |||||||||
cash-flows.row.other-financing-activites | -6.49 | -6.1 | -9.2 | 1059.1 | |||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | -53.41 | -95 | -81 | 994.8 | |||||||||
cash-flows.row.effect-of-forex-changes-on-cash | -22.83 | 0 | 0 | 0 | |||||||||
cash-flows.row.net-change-in-cash | -119.02 | -113.6 | -0.4 | 1117.4 | |||||||||
cash-flows.row.cash-at-end-of-period | 4637.17 | 1247.7 | 1361.3 | 1361.7 | |||||||||
cash-flows.row.cash-at-beginning-of-period | 4756.19 | 1361.3 | 1361.7 | 244.4 | |||||||||
cash-flows.row.operating-cash-flow | 94.38 | 86.2 | 157.4 | 120.8 | |||||||||
cash-flows.row.capital-expenditure | -103.09 | -95.6 | -87.3 | -11.7 | |||||||||
cash-flows.row.free-cash-flow | -8.71 | -9.4 | 70 | 109.1 |
Ред за отчет за приходите
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2014 | 2013 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 462.22 | 462.2 | 321.6 | 430 | ||||||||||
income-statement-row.row.cost-of-revenue | 189.61 | 0 | 88.5 | 108.5 | ||||||||||
income-statement-row.row.gross-profit | 272.62 | 462.2 | 233.1 | 321.6 | ||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | ||||||||||
income-statement-row.row.research-development | 83.41 | - | - | - | ||||||||||
income-statement-row.row.selling-general-administrative | 66.19 | - | - | - | ||||||||||
income-statement-row.row.selling-and-marketing-expenses | 175.09 | - | - | - | ||||||||||
income-statement-row.row.other-expenses | -3.32 | 0 | 18 | 7.4 | ||||||||||
income-statement-row.row.operating-expenses | 312.43 | 312 | 162.9 | 163.1 | ||||||||||
income-statement-row.row.cost-and-expenses | 502.03 | 312 | 251.4 | 271.6 | ||||||||||
income-statement-row.row.interest-income | 6.14 | 0 | 19.3 | 16.8 | ||||||||||
income-statement-row.row.interest-expense | 1 | 0 | 0.3 | 0.2 | ||||||||||
income-statement-row.row.selling-and-marketing-expenses | 175.09 | - | - | - | ||||||||||
income-statement-row.row.total-other-income-expensenet | -20.63 | 1.6 | 1.4 | 2.7 | ||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | ||||||||||
income-statement-row.row.other-operating-expenses | -3.32 | 0 | 18 | 7.4 | ||||||||||
income-statement-row.row.total-operating-expenses | -20.63 | 1.6 | 1.4 | 2.7 | ||||||||||
income-statement-row.row.interest-expense | 1 | 0 | 0.3 | 0.2 | ||||||||||
income-statement-row.row.depreciation-and-amortization | 5.76 | 15.4 | 19.5 | 14.9 | ||||||||||
income-statement-row.row.ebitda-caps | 176.57 | - | - | - | ||||||||||
income-statement-row.row.operating-income | 170.81 | 148.6 | 104.5 | 194.7 | ||||||||||
income-statement-row.row.income-before-tax | 150.18 | 150.2 | 105.8 | 197.4 | ||||||||||
income-statement-row.row.income-tax-expense | 13.75 | 13.7 | 12 | 19.8 | ||||||||||
income-statement-row.row.net-income | 136.43 | 136.4 | 93.8 | 177.8 |
Често задавани въпроси
Какво е Nanjing Vishee Medical Technology Co., Ltd (688580.SS) общи активи?
Nanjing Vishee Medical Technology Co., Ltd (688580.SS) общите активи са 0.000.
Какъв е годишният приход на предприятието?
Годишните приходи са 242425921.000.
Какъв е маржът на печалбата на предприятието?
Маржът на печалбата на фирмата е -0.128.
Какъв е свободният паричен поток на компанията?
Свободният паричен поток е -0.128.
Какъв е маржът на нетната печалба на предприятието?
Маржът на нетната печалба е 0.295.
Какъв е общият приход на предприятието?
Общият приход е 0.370.
Каква е Nanjing Vishee Medical Technology Co., Ltd (688580.SS) нетна печалба (нетен доход)?
Нетната печалба (нетният доход) е 136430800.000.
Какъв е общият дълг на фирмата?
Общият дълг е 0.000.
Какъв е броят на оперативните разходи?
Оперативните разходи са 312046000.000.
Какъв е броят на паричните средства на фирмата?
Паричните средства на предприятието са -1133178524.000.